Arcturus Therapeutics Holdings (ARCT) Consolidated Net Income (2018 - 2025)
Historic Consolidated Net Income for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$13.4 million.
- Arcturus Therapeutics Holdings' Consolidated Net Income fell 9481.38% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 656.73%. This contributed to the annual value of -$80.9 million for FY2024, which is 17229.94% down from last year.
- As of Q3 2025, Arcturus Therapeutics Holdings' Consolidated Net Income stood at -$13.4 million, which was down 9481.38% from -$9.2 million recorded in Q2 2025.
- Over the past 5 years, Arcturus Therapeutics Holdings' Consolidated Net Income peaked at $118.6 million during Q4 2022, and registered a low of -$57.7 million during Q1 2021.
- For the 5-year period, Arcturus Therapeutics Holdings' Consolidated Net Income averaged around -$17.9 million, with its median value being -$21.6 million (2022).
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Consolidated Net Income plummeted by 50944.83% in 2021, and later skyrocketed by 41516.0% in 2022.
- Over the past 5 years, Arcturus Therapeutics Holdings' Consolidated Net Income (Quarter) stood at -$37.6 million in 2021, then skyrocketed by 415.16% to $118.6 million in 2022, then crashed by 109.84% to -$11.7 million in 2023, then tumbled by 156.89% to -$30.0 million in 2024, then skyrocketed by 55.18% to -$13.4 million in 2025.
- Its Consolidated Net Income was -$13.4 million in Q3 2025, compared to -$9.2 million in Q2 2025 and -$14.1 million in Q1 2025.